Diabetes Mellitus, Type 2: all 9,589 studies
Page 96 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCompletedNCT00099619Phase 3
- Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)CompletedNCT00099515Phase 2
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsCompletedNCT00099333Phase 2
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminCompletedNCT00099320Phase 3
- Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00097877Phase 3
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT00097279Phase 3
- Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 DiabetesCompletedNCT00097084Phase 3
- NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCompletedNCT00095446Phase 4
- Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneCompletedNCT00095030Phase 3
- Mechanism of Action and Efficacy of Muraglitazar in Type 2 DiabetesCompletedNCT00094991Phase 3
- Rosiglitazone to Reverse Metabolic Defects in DiabetesCompletedNCT00094796Phase 2
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00085969Phase 2
- Dietary Fiber and Cardiovascular Inflammatory MarkersCompletedNCT00085800
- Genetic Markers of Coronary Heart Disease in Type 2 DiabetesCompletedNCT00078052
- Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment ModelCompletedNCT00074633Not applicable
- Insulin Resistance and Insulin SecretionWithdrawnNCT00073294Not applicable
- Prevention of Type 2 Diabetes Mellitus in ChildrenCompletedNCT00073268Phase 1
- Improving Medication Adherence in Comorbid ConditionsCompletedNCT00072891Not applicable
- Safety and Efficacy of INGAP-Peptide in Patients With Type 2 DiabetesCompletedNCT00071422Phase 2
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.CompletedNCT00069836Phase 3
- Regional Fatty Acid Metabolism in HumansWithdrawnNCT00068887
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedNCT00067951Phase 3
- VLDL and LDL Particle Types as Coronary Heart Disease Risk FactorsCompletedNCT00065793
- Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 DiabetesCompletedNCT00065676Phase 2
- Pilot Study of Vedic Medicine for Type 2 DiabetesCompletedNCT00065650Phase 2
- An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 DiabetesCompletedNCT00065312Phase 2
- Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And HypertensionCompletedNCT00060931Phase 4
- Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionCompletedNCT00060918Phase 4
- Study of Ro 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057317Phase 2
- Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057304Phase 2
- Weight Loss Maintenance (WLM)CompletedNCT00054925Not applicable
- Evaluation of an Orally Administered Medication When Taken in Conjunction With PramlintideCompletedNCT00044707Phase 2
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00044694Phase 2
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCompletedNCT00044668Phase 3
- Efficacy and Safety In Poorly Controlled Type 2 DiabeticsCompletedNCT00044460Phase 4
- Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & ThiazolidinedioneCompletedNCT00044447Phase 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044408Phase 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044395Phase 3
- Evaluation of the Effect of Pramlintide on Satiety and Food IntakeCompletedNCT00042601Phase 2
- Evaluation of the Bioavailability of PramlintideCompletedNCT00042471Phase 2
- Screening Adolescents for Type 2 Diabetes Mellitus in a Community ClinicStatus unknownNCT00042042Not applicable
- Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye StudyCompletedNCT00041444
- Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2DCompletedNCT00041405
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaCompletedNCT00039026Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCompletedNCT00039013Phase 3
- Epidemiology of Cardiovascular Disease in DiabetesCompletedNCT00037297
- Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and WomenCompletedNCT00037258
- Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without InsulinCompletedNCT00036504Phase 4
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00035984Phase 3
- VA HDL Intervention Trial (VA-HIT) Ancillary Study Data AnalysisCompletedNCT00035711
- A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 DiabetesCompletedNCT00035568Phase 4
- A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.CompletedNCT00035542Phase 3
- Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient PatientsCompletedNCT00034255Phase 1/2
- Ginkgo Biloba Extract and the Insulin Resistance SyndromeCompletedNCT00032474Phase 1/2
- Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEADCompletedNCT00031239
- Biomarkers of Oxidative Stress in LOOK AHEAD - Ancillary to LOOK AHEADCompletedNCT00031226
- Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEADCompletedNCT00031213
- MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEADCompletedNCT00031200
- Obese Patients With Type 2 DiabetesCompletedNCT00029848Phase 3
- Prenatal Nutrition and Adult DiseaseCompletedNCT00024583
- Randomized Trial of Health Events Costs in Diabetic BlacksCompletedNCT00022750Not applicable
- Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic ControlCompletedNCT00021944
- Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNTCompletedNCT00021918
- Treating Periodontal Infection: Effects on GlycemicCompletedNCT00016835Phase 2
- NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 DiabetesCompletedNCT00013910Phase 1
- Effects of Reiki on Painful Neuropathy and Cardiovascular Risk FactorsCompletedNCT00010751Phase 2
- NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And YouCompletedNCT00007800Phase 2
- Acute Glycemic Effects of a Very Low Fat Diet in Type 2 DiabetesCompletedNCT00006432Not applicable
- Native Hawaiian Diabetes Intervention ProgramCompletedNCT00006165Not applicable
- Computer-assisted Diabetes Self-management InterventionsCompletedNCT00006163Phase 4
- Lifestyle Interventions to Reduce Diabetes RiskCompletedNCT00006162Not applicable
- Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 DiabetesCompletedNCT00005760
- Diet, Insulin Resistance, and Cardiovascular RiskCompletedNCT00005530
- Multi-Ethnic Study of Atherosclerosis (MESA)Active, not recruitingNCT00005487
- Diabetes, Lipoproteins and Accelerated Vascular DiseaseCompletedNCT00005479
- Genetics of Atherosclerosis in Mexican AmericansCompletedNCT00005462
- Lifestyle Management for Women With CHD and NIDDMCompletedNCT00005441
- Physical Activity, Hypertension, Diabetes, and Coronary Heart DiseaseCompletedNCT00005419
- Genetics of the Metabolic Syndrome in Japanese AmericansCompletedNCT00005374
- Central Obesity and Disease Risk in Japanese AmericansCompletedNCT00005365
- Incidence of Diabetes and Cardiovascular Disease in Mexican AmericansCompletedNCT00005205
- Prospective Study of Diabetes-related Vascular Disease in Oklahoma IndiansCompletedNCT00005193
- Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)CompletedNCT00005146
- Heritage Study--Genetics, Exercise and Risk FactorsCompletedNCT00005137Not applicable
- Diabetes Prevention ProgramCompletedNCT00004992Phase 3
- Education and Group Support for Diabetic HispanicsCompletedNCT00004983Not applicable
- Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic PatientsStatus unknownNCT00004572
- Study of the Effects of Vitamin C on Patients With Type 2 DiabetesCompletedNCT00001870Phase 2
- Methods for Measuring Insulin SensitivityCompletedNCT00001625